← Leaderboards
Seymour Packman
University Of California San Francisco
$961,450
Attributed
$961,450
Total exposure
6
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $185.5K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$961,450 · 6
By mechanism
T32$851,063 · 1
M01$110,387 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Stanley B Prusiner$54,781,835
- Richard W Price$15,279,456
- Philip A Starr$13,081,549
- Kenneth D Laxer$6,044,845
- Anthony James Barkovich$7,897,483
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationMetabolism Disorder ChemotherapyInborn Carbohydrate Metabolism DisorderInborn Aminoacid Metabolism DisorderFamily GeneticsMenkes'SyndromePathologic ProcessChild (0-11)Patient Oriented ResearchRecombinant ProteinsClinical TrialsEnzyme TherapyFabry'S DiseaseKidney FunctionAlpha GalactosidaseInborn Metabolism DisorderInborn Metabolism Disorder DiagnosisPost-Doctoral TrainingDrug Screening /EvaluationCreatinineCardiovascular FunctionBrain Disorders
Grant awards (22)
Postdoctoral Training in Medical Genetics$118,040
T32 · FY2007 · GM · contact PI
Postdoctoral Training in Medical Genetics$185,475
T32 · FY2006 · GM · contact PI
Postdoctoral Training in Medical Genetics$75,806
T32 · FY2005 · GM
MULTI-CENTER, OPEN LABEL OF FABRAZYME IN PATIENTS WITH FABRY DISEASE$28,989
M01 · FY2005 · RR
CLINICAL INVESTIGATION OF THE PATIENT WITH INBORN ERROR OF METABOLISM$16,147
M01 · FY2005 · RR
Postdoctoral Training in Medical Genetics$180,214
T32 · FY2004 · GM
Clinical investigation of the patient with inborn error of metabolism$15,471
M01 · FY2004 · RR
Multi-center, open label of Fabrazyme in patients with Fabry disease$5,950
M01 · FY2004 · RR
Safety and efficacy of recombinant human alpha-galactosidase A$574
M01 · FY2004 · RR
Postdoctoral Training in Medical Genetics$165,699
T32 · FY2003 · GM
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2002 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2002 · RR
POSTDOCTORAL TRAINING IN MEDICAL GENETICS$43,622
T32 · FY2001 · GM
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2001 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2001 · RR
POSTDOCTORAL TRAINING IN MEDICAL GENETICS$82,207
T32 · FY2000 · GM
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$25,799
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$17,457
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2000 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2000 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2000 · RR